Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-09-13 Purchase |
2023-09-14 11:36 am |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
50,900 | $0.9828 | $50,025 | 130,400 (Direct) |
View |
2023-03-21 Sale |
2023-03-24 3:48 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
26,500 | $1.5131 | $40,097 | 337,494 (Direct) |
View |
2022-06-15 Purchase |
2022-06-16 09:54 am |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
10,000 | $1.0219 | $10,219 | 67,000 (Direct) |
View |
2022-06-10 Purchase |
2022-06-14 4:16 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
14,000 | $1.0558 | $14,781 | 57,000 (Direct) |
View |
2022-05-20 Purchase |
2022-05-24 4:03 pm |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
28,000 | $0.90054 | $25,215 | 43,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-10-31 Tax Withholding |
2023-11-02 3:56 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $0.9 | 534,446 (Direct) |
View |
2023-09-30 Tax Withholding |
2023-10-03 3:40 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $0.8904 | 83,932 (Direct) |
View |
2023-09-30 Tax Withholding |
2023-10-03 3:31 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $0.8904 | 350,864 (Direct) |
View |
2023-09-30 Tax Withholding |
2023-10-03 3:21 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $0.8904 | 536,685 (Direct) |
View |
2023-08-31 Tax Withholding |
2023-09-05 11:48 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $0.8505 | 84,184 (Direct) |
View |
2023-08-31 Tax Withholding |
2023-09-05 11:34 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $0.8505 | 350,954 (Direct) |
View |
2023-08-31 Tax Withholding |
2023-09-05 11:25 am |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $0.8505 | 538,924 (Direct) |
View |
2023-07-31 Tax Withholding |
2023-08-01 4:00 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.02 | 84,436 (Direct) |
View |
2023-07-31 Tax Withholding |
2023-08-01 3:51 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.02 | 351,044 (Direct) |
View |
2023-07-31 Tax Withholding |
2023-08-01 3:35 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.02 | 541,163 (Direct) |
View |
2023-06-30 Tax Withholding |
2023-07-05 2:08 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.2 | 84,688 (Direct) |
View |
2023-06-30 Tax Withholding |
2023-07-05 1:57 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.2 | 351,134 (Direct) |
View |
2023-06-30 Tax Withholding |
2023-07-05 1:49 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.2 | 543,402 (Direct) |
View |
2023-05-31 Tax Withholding |
2023-06-01 4:57 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.21 | 84,940 (Direct) |
View |
2023-05-31 Tax Withholding |
2023-06-01 4:46 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.21 | 351,224 (Direct) |
View |
2023-05-31 Tax Withholding |
2023-06-01 4:36 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.21 | 545,641 (Direct) |
View |
2023-04-30 Tax Withholding |
2023-05-02 3:48 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.54 | 85,192 (Direct) |
View |
2023-04-30 Tax Withholding |
2023-05-02 3:40 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.54 | 351,314 (Direct) |
View |
2023-04-30 Tax Withholding |
2023-05-02 3:29 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.54 | 547,880 (Direct) |
View |
2023-04-21 Option Award |
2023-04-25 3:39 pm |
N/A 2033-04-20 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | McClurg Ronald W. Chief Financial Officer |
12,500 | $0 | 92,000 (Direct) |
View |
2023-04-21 Option Award |
2023-04-25 3:27 pm |
N/A 2033-04-20 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
50,000 | $0 | 135,444 (Direct) |
View |
2023-04-21 Option Award |
2023-04-25 3:14 pm |
N/A 2033-04-20 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
14,000 | $0 | 365,404 (Direct) |
View |
2023-04-21 Option Award |
2023-04-25 2:58 pm |
N/A 2033-04-20 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
91,500 | $0 | 641,619 (Direct) |
View |
2023-03-31 Tax Withholding |
2023-04-04 4:31 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
252 | $1.61 | 35,444 (Direct) |
View |
2023-03-31 Tax Withholding |
2023-04-04 4:22 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
90 | $1.61 | 337,404 (Direct) |
View |
2023-03-31 Tax Withholding |
2023-04-04 4:12 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
2,239 | $1.61 | 458,619 (Direct) |
View |
2023-03-16 Option Award |
2023-03-20 2:06 pm |
N/A 2033-03-16 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | MATHIESEN JEFFREY S Director |
39,503 | $0 | 105,563 (Direct) |
View |
2023-03-16 Option Award |
2023-03-20 1:51 pm |
N/A 2033-03-16 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director |
39,503 | $0 | 100,175 (Direct) |
View |
2023-03-16 Option Award |
2023-03-20 1:39 pm |
N/A 2033-03-16 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director |
39,503 | $0 | 83,152 (Direct) |
View |
2023-02-03 Tax Withholding |
2023-02-07 4:44 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Mertens Steve Chief Technology Officer |
6,054 | $1.47 | 35,696 (Direct) |
View |
2023-02-03 Tax Withholding |
2023-02-07 4:37 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Christianson Mark Business Development Director Director |
2,175 | $1.47 | 363,994 (Direct) |
View |
2023-02-03 Tax Withholding |
2023-02-07 4:18 pm |
N/A N/A |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Rosa David A CEO and President |
53,750 | $1.47 | 460,858 (Direct) |
View |
2022-05-31 Option Award |
2022-06-02 4:22 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | MATHIESEN JEFFREY S Director |
58,470 | $0 | 95,290 (Direct) |
View |
2022-05-31 Option Award |
2022-06-02 4:12 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | BUCKMAN PAUL Director |
58,470 | $0 | 89,902 (Direct) |
View |
2022-05-31 Option Award |
2022-06-02 4:02 pm |
N/A 2032-05-31 |
NEUROONE MEDICAL TECHNOLOGIES Corp | NMTC | Andrle Edward Director |
58,470 | $0 | 72,879 (Direct) |
View |